Adeno-associated viruses from primates & derived vectors (updated 2024) [PDF, 392KB]
Adenovirus-based vaccine strain Ad26.COVS1 (J&J, 2020) (not accessible) [PDF, 498KB]
Adenovirus-based vaccine strain Ad26.ZEBOV (Zabdeno, 2021) (not accessible) [PDF, 493KB]
Adenovirus-based vaccine strain ChAdOx1 nCoV-19 (AstraZeneca, 2020) (not accessible) [PDF, 510KB]
Adenovirus-based vaccine strains rAd5-S-CoV2 & rAD26-S-CoV2 (SputnikV, 2021) (not accessible) [PDF, 490KB]
Adenoviruses from primates_gene transfer with (updated 2021) (not accessible) [PDF, 608KB]
RNA viruses: minigenomes, replicons & virus-like particles (2021) (not accessible) [PDF, 639KB]
Current classifications
Statements on safety-related issues in genetic engineering work or facilities
The ZKBS adopts general recommendations (position statements) on safety-relevant issues that often occur in genetic engineering operations or in genetic engineering facilities. Such general recommendations relate in particular to the risk assessment of organism, the containment level assignment of genetic engineering work or the assessment of safety-related measurements.